Rajiv is from McKinsey. He is trained at one thing - cutting costs to make the bottom line look better. it's not about people or products or culture. He is a Mckinsey boy who never grew up in pharma. No surprise and more to come if the numbers don't meet his commitment to the street. This is what MckInsey does over and over again.